CA2654981C - Methods for assaying percentage of glycated hemoglobin - Google Patents
Methods for assaying percentage of glycated hemoglobin Download PDFInfo
- Publication number
- CA2654981C CA2654981C CA2654981A CA2654981A CA2654981C CA 2654981 C CA2654981 C CA 2654981C CA 2654981 A CA2654981 A CA 2654981A CA 2654981 A CA2654981 A CA 2654981A CA 2654981 C CA2654981 C CA 2654981C
- Authority
- CA
- Canada
- Prior art keywords
- glycated
- oxidizing agent
- protease
- hemoglobin
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 102
- 102000017011 Glycated Hemoglobin A Human genes 0.000 title claims abstract description 93
- 108091005995 glycated hemoglobin Proteins 0.000 title claims abstract description 93
- 239000007800 oxidant agent Substances 0.000 claims abstract description 142
- 239000004365 Protease Substances 0.000 claims abstract description 96
- 108091005804 Peptidases Proteins 0.000 claims abstract description 95
- 210000004369 blood Anatomy 0.000 claims abstract description 92
- 239000008280 blood Substances 0.000 claims abstract description 92
- 102000035195 Peptidases Human genes 0.000 claims abstract description 71
- 102000001554 Hemoglobins Human genes 0.000 claims abstract description 62
- 108010054147 Hemoglobins Proteins 0.000 claims abstract description 62
- 108010078123 amadoriase Proteins 0.000 claims abstract description 61
- 239000000126 substance Substances 0.000 claims abstract description 56
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 39
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 39
- 238000005259 measurement Methods 0.000 claims abstract description 10
- 235000019419 proteases Nutrition 0.000 claims description 85
- 230000002934 lysing effect Effects 0.000 claims description 52
- 239000000872 buffer Substances 0.000 claims description 46
- 150000001413 amino acids Chemical class 0.000 claims description 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 41
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 35
- 239000012634 fragment Substances 0.000 claims description 34
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical group C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 30
- 102000004169 proteins and genes Human genes 0.000 claims description 29
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 26
- 238000011088 calibration curve Methods 0.000 claims description 24
- 210000003743 erythrocyte Anatomy 0.000 claims description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 17
- -1 ananine Proteins 0.000 claims description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 15
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 claims description 13
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 claims description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 11
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 11
- 239000004474 valine Substances 0.000 claims description 11
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 10
- 210000000601 blood cell Anatomy 0.000 claims description 9
- 239000004471 Glycine Substances 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 8
- 208000035475 disorder Diseases 0.000 claims description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 6
- CWLYDTVACYGEPD-UHFFFAOYSA-M sodium;2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetate Chemical compound [Na+].C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC([O-])=O)C2=C1 CWLYDTVACYGEPD-UHFFFAOYSA-M 0.000 claims description 6
- 241000228212 Aspergillus Species 0.000 claims description 5
- 108090000145 Bacillolysin Proteins 0.000 claims description 5
- 108010067770 Endopeptidase K Proteins 0.000 claims description 5
- 102000035092 Neutral proteases Human genes 0.000 claims description 5
- 108091005507 Neutral proteases Proteins 0.000 claims description 5
- 108010059712 Pronase Proteins 0.000 claims description 5
- 108090000787 Subtilisin Proteins 0.000 claims description 5
- 108090001109 Thermolysin Proteins 0.000 claims description 5
- 125000000539 amino acid group Chemical group 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 238000003745 diagnosis Methods 0.000 claims description 4
- 210000000496 pancreas Anatomy 0.000 claims description 4
- 238000004393 prognosis Methods 0.000 claims description 4
- NXTVQNIVUKXOIL-UHFFFAOYSA-N N-chlorotoluene-p-sulfonamide Chemical compound CC1=CC=C(S(=O)(=O)NCl)C=C1 NXTVQNIVUKXOIL-UHFFFAOYSA-N 0.000 claims description 3
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 claims description 3
- 239000001230 potassium iodate Substances 0.000 claims description 3
- 235000006666 potassium iodate Nutrition 0.000 claims description 3
- 229940093930 potassium iodate Drugs 0.000 claims description 3
- AGDSCTQQXMDDCV-UHFFFAOYSA-M sodium;2-iodoacetate Chemical compound [Na+].[O-]C(=O)CI AGDSCTQQXMDDCV-UHFFFAOYSA-M 0.000 claims description 3
- 229960001479 tosylchloramide sodium Drugs 0.000 claims description 3
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 24
- SMBKJPHMYWYRDF-UHFFFAOYSA-M sodium 4-[2-(2,4-dinitrophenyl)-3-(4-iodophenyl)-1,3-dihydrotetrazol-3-ium-5-yl]benzene-1,3-disulfonate Chemical group [Na+].[O-][N+](=O)C1=CC([N+](=O)[O-])=CC=C1N1[NH+](C=2C=CC(I)=CC=2)N=C(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)N1 SMBKJPHMYWYRDF-UHFFFAOYSA-M 0.000 claims 2
- VHYHKZFQXUYNSG-UHFFFAOYSA-M sodium;4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-1,3-dihydrotetrazol-3-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[NH+](C=2C=CC(I)=CC=2)N=C(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)N1 VHYHKZFQXUYNSG-UHFFFAOYSA-M 0.000 claims 2
- 238000006911 enzymatic reaction Methods 0.000 abstract description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 35
- 230000002255 enzymatic effect Effects 0.000 description 21
- 230000001590 oxidative effect Effects 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 17
- 238000003556 assay Methods 0.000 description 16
- 239000006166 lysate Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000012139 lysis buffer Substances 0.000 description 12
- 102000004316 Oxidoreductases Human genes 0.000 description 9
- 108090000854 Oxidoreductases Proteins 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 108091005996 glycated proteins Proteins 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 6
- 239000007987 MES buffer Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920004890 Triton X-100 Polymers 0.000 description 4
- 239000013504 Triton X-100 Substances 0.000 description 4
- 238000007824 enzymatic assay Methods 0.000 description 4
- DCNMIDLYWOTSGK-HSUXUTPPSA-N D-glucosone Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C=O DCNMIDLYWOTSGK-HSUXUTPPSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000006325 deglycation Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 2
- 239000008000 CHES buffer Substances 0.000 description 2
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- IVNALXNJOCZGMK-UHFFFAOYSA-M [4-[4-(dimethylamino)phenyl]iminocyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride Chemical class [Cl-].C1=CC(N(C)C)=CC=C1N=C1C=CC(=[N+](C)C)C=C1 IVNALXNJOCZGMK-UHFFFAOYSA-M 0.000 description 2
- 150000001323 aldoses Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 125000001151 peptidyl group Chemical group 0.000 description 2
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 150000004060 quinone imines Chemical class 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 1
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 238000003691 Amadori rearrangement reaction Methods 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- SXGAGTVDWKQYCX-BQBZGAKWSA-N Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SXGAGTVDWKQYCX-BQBZGAKWSA-N 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 238000008466 HbA1C Enzymatic Assay Methods 0.000 description 1
- 238000008479 Hemoglobin A1c Assay Methods 0.000 description 1
- MAJYPBAJPNUFPV-BQBZGAKWSA-N His-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MAJYPBAJPNUFPV-BQBZGAKWSA-N 0.000 description 1
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 1
- JPNRPAJITHRXRH-BQBZGAKWSA-N Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O JPNRPAJITHRXRH-BQBZGAKWSA-N 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- BEPSGCXDIVACBU-IUCAKERBSA-N Pro-His Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CN=CN1 BEPSGCXDIVACBU-IUCAKERBSA-N 0.000 description 1
- RZEQTVHJZCIUBT-WDSKDSINSA-N Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-WDSKDSINSA-N 0.000 description 1
- UJTZHGHXJKIAOS-WHFBIAKZSA-N Ser-Gln Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O UJTZHGHXJKIAOS-WHFBIAKZSA-N 0.000 description 1
- LZLREEUGSYITMX-JQWIXIFHSA-N Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)N)C(O)=O)=CNC2=C1 LZLREEUGSYITMX-JQWIXIFHSA-N 0.000 description 1
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 1
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- ZSXJENBJGRHKIG-UWVGGRQHSA-N Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UWVGGRQHSA-N 0.000 description 1
- JAQGKXUEKGKTKX-HOTGVXAUSA-N Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 JAQGKXUEKGKTKX-HOTGVXAUSA-N 0.000 description 1
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009459 flexible packaging Methods 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104998—Glucose, ketone, nitrate standard or control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83339006P | 2006-07-25 | 2006-07-25 | |
| US60/833,390 | 2006-07-25 | ||
| US85880906P | 2006-11-13 | 2006-11-13 | |
| US60/858,809 | 2006-11-13 | ||
| PCT/US2007/016774 WO2008013874A1 (en) | 2006-07-25 | 2007-07-25 | Methods for assaying percentage of glycated hemoglobin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2654981A1 CA2654981A1 (en) | 2008-01-31 |
| CA2654981C true CA2654981C (en) | 2016-05-17 |
Family
ID=38645830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2654981A Active CA2654981C (en) | 2006-07-25 | 2007-07-25 | Methods for assaying percentage of glycated hemoglobin |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7855079B2 (enExample) |
| EP (1) | EP2044444B1 (enExample) |
| JP (3) | JP2009544315A (enExample) |
| CN (1) | CN101484809B (enExample) |
| AU (1) | AU2007277201B2 (enExample) |
| CA (1) | CA2654981C (enExample) |
| ES (1) | ES2404059T3 (enExample) |
| WO (1) | WO2008013874A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610792D0 (en) * | 2006-06-02 | 2006-07-12 | Remynd Nv | Methods and tools for the screening of factors affecting protein misfolding |
| US7855079B2 (en) | 2006-07-25 | 2010-12-21 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| US7943385B2 (en) * | 2006-07-25 | 2011-05-17 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| WO2009140343A1 (en) * | 2008-05-13 | 2009-11-19 | General Atomics | Electrochemical biosensor for direct determination of percentage of glycated hemoglobin |
| JP5554000B2 (ja) * | 2009-02-19 | 2014-07-23 | 積水メディカル株式会社 | 糖化ヘモグロビン測定用試料の測定方法 |
| WO2010124976A2 (en) * | 2009-04-28 | 2010-11-04 | Dsm Ip Assets B.V. | A method for improving a bean-based product |
| US8703494B2 (en) * | 2009-05-20 | 2014-04-22 | Relia Diagnostic Systems, Llc | Systems and methods for determining the percentage of glycated hemoglobin |
| CA2806261A1 (en) * | 2010-08-11 | 2012-02-16 | Kyowa Medex Co., Ltd. | Method for measuring glycated hemoglobin |
| JP2012108112A (ja) * | 2010-10-27 | 2012-06-07 | Arkray Inc | ＨｂＡ１ｃ測定結果の表示方法、表示装置、及び表示プログラム |
| KR20140027383A (ko) * | 2011-06-17 | 2014-03-06 | 교와 메덱스 가부시키가이샤 | 당화 헤모글로빈의 측정 방법, 측정 시약, 및 측정 키트 |
| TW201312118A (zh) * | 2011-09-15 | 2013-03-16 | Toyo Boseki | 糖化血紅素測量用多層試驗片、及使用它之測量方法 |
| EP2813577A4 (en) * | 2012-02-09 | 2015-07-15 | Kyowa Medex Co Ltd | METHOD OF SUPPRESSING THE EFFECTS OF ASCORBIC ACID |
| CN102692411B (zh) * | 2012-06-08 | 2016-12-14 | 上海蓝怡科技股份有限公司 | 一种测定糖化血红蛋白百分比的试剂 |
| CN102998289B (zh) * | 2012-11-14 | 2015-05-20 | 广西安仁欣生物科技有限公司 | 基于核酸适体荧光探针的糖化血红蛋白试剂盒及其检测方法 |
| CN104164473A (zh) * | 2013-05-16 | 2014-11-26 | 北京豪迈生物工程有限公司 | 糖化白蛋白酶法检测试剂盒及其检测方法 |
| WO2014192200A1 (ja) * | 2013-05-31 | 2014-12-04 | パナソニックヘルスケア株式会社 | 糖化ヘモグロビンを定量する方法 |
| WO2015005257A1 (ja) * | 2013-07-09 | 2015-01-15 | 協和メデックス株式会社 | 糖化ヘモグロビンの測定方法 |
| ES2848705T3 (es) * | 2013-08-09 | 2021-08-11 | Kikkoman Corp | Amadoriasa modificada y método para producirla, agente para mejorar la resistencia a tensioactivos de la amadoriasa y composición para medir la HbA1c usando la misma |
| CN106461682B (zh) | 2014-05-06 | 2018-09-21 | 德赛诊断系统有限公司 | HbA1c的酶促测定 |
| EP3239709B1 (en) * | 2016-04-25 | 2019-06-05 | ARKRAY, Inc. | Method of analyzing glycated protein; use of analysis reagent, analysis kit, and test piece for analysis |
| EP3550030B1 (en) * | 2016-11-30 | 2025-01-01 | Toyobo Co., Ltd. | Method for measuring glycation rate of hemoglobin |
| IT201700070452A1 (it) * | 2017-06-23 | 2018-12-23 | Fondazione St Italiano Tecnologia | Thermostabilized amadoriases and uses thereof |
| CN109682796A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
| CN108732222B (zh) * | 2018-05-21 | 2020-02-18 | 浙江工业大学 | 一种同时快速检测血液中糖化血红蛋白和糖化血清蛋白的方法 |
| CN109596834B (zh) * | 2018-10-18 | 2021-09-10 | 东软威特曼生物科技(南京)有限公司 | 一种应用于体外诊断试剂的表面活性剂组合物 |
| JP7182724B2 (ja) * | 2019-02-15 | 2022-12-02 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 患者の液体試験サンプル中の糖化ヘモグロビンパーセントを決定するためのキャリブレーターおよびコントロール |
| CN110297048A (zh) * | 2019-07-12 | 2019-10-01 | 上海交通大学 | 一种抗干扰的糖化血红蛋白同系物相对含量的测定方法 |
| CN114667097A (zh) * | 2019-07-22 | 2022-06-24 | 奥索临床诊断有限公司 | 糖化血红蛋白测量 |
| CN110687306B (zh) * | 2019-10-30 | 2023-04-25 | 深圳上泰生物工程有限公司 | 一种直接机上溶血酶法双试剂糖化血红蛋白检测试剂盒 |
| WO2021192466A1 (ja) * | 2020-03-26 | 2021-09-30 | 日立化成ダイアグノスティックス・システムズ株式会社 | ヘモグロビンの影響軽減方法、糖化ヘモグロビンの測定方法、糖化ヘモグロビン測定試薬、及び糖化ヘモグロビン測定キット |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2713581A (en) | 1949-02-23 | 1955-07-19 | Montclair Res Corp | Certain tetrazolium salts and process for preparing them |
| GB738585A (en) | 1952-07-17 | 1955-10-19 | May & Baker Ltd | Improvements in or relating to tetrazolium compounds |
| GB1513488A (en) | 1976-11-11 | 1978-06-07 | Lushina O | Method of preparing 2h-tetrazolium chlorides and 2h-tetrazolium chlorides hydrochlorides |
| GB8308483D0 (en) | 1983-03-28 | 1983-05-05 | Health Lab Service Board | Secretion of gene products |
| US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
| US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
| CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
| US5509410A (en) | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
| JPS59219270A (ja) | 1983-05-30 | 1984-12-10 | Wako Pure Chem Ind Ltd | テトラゾリウム塩を含有する溶液の安定化方法 |
| BE901119A (fr) | 1984-11-23 | 1985-03-15 | Wallone Region | Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue. |
| US4571488A (en) | 1985-01-29 | 1986-02-18 | E. I. Du Pont De Nemours And Company | Heat-fusion pipe fitting system |
| US4948729A (en) | 1985-03-25 | 1990-08-14 | Cetus Corporation | Production of soluble recombinant proteins |
| EP0196864A3 (en) | 1985-03-25 | 1988-03-23 | Cetus Corporation | Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences |
| EP0204523B1 (en) | 1985-05-31 | 1992-02-26 | Syntex (U.S.A.) Inc. | Glucose-6-phosphate dehydrogenase conjugates, their preparation and use |
| DE3611227A1 (de) | 1986-04-04 | 1987-10-08 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur bestimmung von substraten oder enzymaktivitaeten |
| US5196314A (en) | 1986-04-04 | 1993-03-23 | Boehringer Mannheim Gmbh | Process and reagent for the determination of substrates or enzyme activities |
| US5030563A (en) | 1987-07-07 | 1991-07-09 | Genetics Institute, Inc. | Bacterial hypersecretion using mutant repressor sequence |
| JP2970811B2 (ja) | 1987-10-30 | 1999-11-02 | オンコゲン ア リミテッド パートナーシップ | 原核生物細胞中にポリペプチドを調製するための発現システム |
| CA1335357C (en) | 1987-10-30 | 1995-04-25 | Timothy M. Rose | Expression systems for preparation of polypeptides in prokaryotic cells |
| WO1989009397A1 (en) | 1988-03-31 | 1989-10-05 | Matsushita Electric Industrial Co., Ltd. | Biosensor and process for its production |
| US5516682A (en) | 1988-07-05 | 1996-05-14 | University Of Maryland | Subtilin variant of enhanced stability and activity |
| JP2742281B2 (ja) | 1988-12-29 | 1998-04-22 | 旭化成工業株式会社 | グルコース―６―リン酸デヒドロゲナーゼ遺伝子 |
| CA2051119A1 (en) | 1989-04-13 | 1990-10-14 | James B. Johnston | Use of fluid insoluble oxidizing agents to eliminate interfering substances in oxidation-reduction measuring systems |
| US5171670A (en) | 1989-05-12 | 1992-12-15 | The General Hospital Corporation | Recombinant dna method for production of parathyroid hormone |
| USRE37919E1 (en) | 1989-05-12 | 2002-12-03 | The General Hospital Corporation | Recombinant DNA method for production of parathyroid hormone |
| JP2796150B2 (ja) | 1989-12-20 | 1998-09-10 | 株式会社ヤトロン | フルクトサミンの測定方法 |
| US5320732A (en) | 1990-07-20 | 1994-06-14 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring apparatus using the same |
| DE4024158A1 (de) | 1990-07-30 | 1992-02-06 | Boehringer Mannheim Gmbh | Klonierung und ueberexpression von glucose-6-phosphat-dehydrogenase aus leuconostoc dextranicus |
| US5244796A (en) | 1990-10-12 | 1993-09-14 | Syracuse University | Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making glucose-6-phospate dehydrogenase |
| MY107664A (en) | 1991-01-17 | 1996-05-30 | Kao Corp | Novel alkaline proteinase and process for producing the same |
| US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| AU2592692A (en) | 1991-09-20 | 1993-04-27 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Isolation and characterization of cdna of plasmodium falciparum glucose-6-phosphate dehydrogenase |
| US5385846A (en) | 1993-06-03 | 1995-01-31 | Boehringer Mannheim Corporation | Biosensor and method for hematocrit determination |
| US5789221A (en) | 1994-03-03 | 1998-08-04 | Kyogo Daiichi Kagaku Co., Ltd. | Fructosyl amino acid oxidase and process for producing the same |
| CA2156226C (en) | 1994-08-25 | 1999-02-23 | Takayuki Taguchi | Biological fluid analyzing device and method |
| US5712138A (en) | 1994-10-05 | 1998-01-27 | Kyoto Daiichi Kagaku Co., Ltd. | Fructosyl amino acid oxidase |
| IL117350A0 (en) | 1995-03-09 | 1996-07-23 | Procter & Gamble | Proteinase k variants having decreased adsorption and increased hydrolysis |
| DE69635503T2 (de) | 1995-04-11 | 2006-08-17 | Arkray, Inc. | Fructosyl-Aminosäureoxidase und Verfahren zu deren Herstellung |
| US6008006A (en) | 1995-05-05 | 1999-12-28 | Genzyme Limited Et Al. | Determination of glycated proteins |
| US5628890A (en) | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
| US5639672A (en) | 1995-10-16 | 1997-06-17 | Lxn Corporation | Electrochemical determination of fructosamine |
| JP3217687B2 (ja) | 1996-02-16 | 2001-10-09 | オリエンタル酵母工業株式会社 | 新規ヘキソキナーゼ |
| IL120587A (en) | 1996-04-04 | 2000-10-31 | Lifescan Inc | Reagent test strip for determination of blood glucose |
| JPH1033177A (ja) | 1996-07-23 | 1998-02-10 | Kdk Corp | フルクトシルアミノ酸オキシダーゼ |
| US5710248A (en) | 1996-07-29 | 1998-01-20 | University Of Iowa Research Foundation | Peptide tag for immunodetection and immunopurification |
| US5856104A (en) | 1996-10-28 | 1999-01-05 | Affymetrix, Inc. | Polymorphisms in the glucose-6 phosphate dehydrogenase locus |
| US5879921A (en) | 1996-11-07 | 1999-03-09 | Novo Nordisk A/S | Recombinant expression of a glucose oxidase from a cladosporium strain |
| US6069297A (en) | 1996-12-09 | 2000-05-30 | Sloan-Kettering Institute For Cancer Research | Glucose-6-phosphate dehydrogenase deficient mice and methods of using same |
| US6127345A (en) | 1997-01-21 | 2000-10-03 | Smithkline Beecham Corporation | Polynucleotides encoding the glucose 6-phosphate dehydrogenase of Streptococcus pneumoniae |
| DE69809391T2 (de) | 1997-02-06 | 2003-07-10 | Therasense, Inc. | Kleinvolumiger sensor zur in-vitro bestimmung |
| EP0921198B1 (en) | 1997-04-24 | 2006-07-19 | ARKRAY, Inc | Method for enzymatically assaying saccharification protein |
| US5972745A (en) | 1997-05-30 | 1999-10-26 | International Business Machines Corporation | Method or forming self-aligned halo-isolated wells |
| JP3987900B2 (ja) | 1997-11-26 | 2007-10-10 | アークレイ株式会社 | 糖化タンパク質の測定方法 |
| US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| GB9824282D0 (en) | 1998-11-05 | 1998-12-30 | Microbiological Research Agenc | Delivery of superoxide dismutase to neuronal cells |
| JP4045322B2 (ja) * | 1998-11-17 | 2008-02-13 | アークレイ株式会社 | 酸化還元反応を用いた測定方法 |
| US6352835B1 (en) * | 1998-11-17 | 2002-03-05 | Kyoto Daiichi Kagaku Co. Ltd. | Method of measuring substance in sample using a redox reaction |
| US6380380B1 (en) | 1999-01-04 | 2002-04-30 | Specialty Assays, Inc. | Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates |
| JP3949854B2 (ja) | 1999-10-01 | 2007-07-25 | キッコーマン株式会社 | 糖化蛋白質の測定方法 |
| US7276146B2 (en) | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| CN1300763A (zh) | 1999-12-23 | 2001-06-27 | 复旦大学 | 一种新的多肽－已糖激酶蛋白12和编码这种多肽的多核苷酸 |
| CN1313391A (zh) | 2000-03-15 | 2001-09-19 | 上海博德基因开发有限公司 | 一种新的多肽——人已糖激酶蛋白10和编码这种多肽的多核苷酸 |
| CN1323837A (zh) | 2000-05-16 | 2001-11-28 | 上海博德基因开发有限公司 | 一种新的多肽——人已糖激酶蛋白11和编码这种多肽的多核苷酸 |
| AU2001263360A1 (en) | 2000-05-19 | 2001-12-03 | Millennium Pharmaceuticals, Inc. | 50365, a hexokinase family member and uses thereof |
| US7078204B2 (en) | 2000-06-21 | 2006-07-18 | Kyowa Hakko Kogyo Co., Ltd. | Glucose-6-phosphate dehydrogenase |
| CN1333350A (zh) | 2000-07-07 | 2002-01-30 | 上海博德基因开发有限公司 | 一种新的多肽——已糖激酶蛋白9.68和编码这种多肽的多核苷酸 |
| EP2336351B1 (en) | 2000-07-14 | 2016-03-09 | ARKRAY, Inc. | Method of selectively determining glycated hemoglobin |
| JPWO2002021142A1 (ja) * | 2000-09-07 | 2004-01-15 | 和光純薬工業株式会社 | 総ヘモグロビン及び糖化ヘモグロビンの測定方法 |
| CN1243982C (zh) * | 2000-09-28 | 2006-03-01 | 爱科来株式会社 | 利用氧化还原反应的测定方法 |
| DE10105911A1 (de) | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Expression der rekombinanten Proteinase K aus Tritirachium album in Hefe |
| DE10105912A1 (de) | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Rekombinante Proteinase K |
| JP3775263B2 (ja) | 2001-08-10 | 2006-05-17 | ニプロ株式会社 | 記録媒体およびこの記録媒体を用いた血糖測定システム |
| DE10155505A1 (de) | 2001-11-13 | 2003-05-22 | Basf Ag | Gene die für Glucose-6-Phosphat-Dehydrogenase Proteine codieren |
| US20030116447A1 (en) | 2001-11-16 | 2003-06-26 | Surridge Nigel A. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| ATE367583T1 (de) * | 2002-01-31 | 2007-08-15 | Arkray Inc | Verfahren zur quantifizierung von glykosyliertem protein unter verwendung einer redoxreaktion sowie eines quantifizierungskits |
| US6863800B2 (en) | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| US6951728B2 (en) | 2002-05-10 | 2005-10-04 | Lifescan, Inc. | Multilayer reagent test strips to quantify glycated protein in a physiological sample |
| AU2003235973A1 (en) * | 2002-06-07 | 2003-12-22 | Arkray, Inc. | Method of assay by oxidation-reduction reaction with formazan |
| JP2004275168A (ja) | 2003-03-17 | 2004-10-07 | Koji Hayade | フルクトシルアミン酸化酵素 |
| US7153666B2 (en) | 2003-07-17 | 2006-12-26 | General Atomics | Methods and compositions for determination of glycated proteins |
| WO2007094354A1 (ja) | 2006-02-14 | 2007-08-23 | National Institute Of Advanced Industrial Science And Technology | ヘモグロビンA1cセンサ |
| US7855079B2 (en) | 2006-07-25 | 2010-12-21 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| US7943385B2 (en) * | 2006-07-25 | 2011-05-17 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
| CN101320035A (zh) | 2007-05-21 | 2008-12-10 | 台达电子工业股份有限公司 | 生物传感器以及其组合物 |
| WO2009140343A1 (en) | 2008-05-13 | 2009-11-19 | General Atomics | Electrochemical biosensor for direct determination of percentage of glycated hemoglobin |
-
2007
- 2007-07-25 US US11/881,179 patent/US7855079B2/en active Active
- 2007-07-25 ES ES07810786T patent/ES2404059T3/es active Active
- 2007-07-25 WO PCT/US2007/016774 patent/WO2008013874A1/en not_active Ceased
- 2007-07-25 CN CN2007800231235A patent/CN101484809B/zh active Active
- 2007-07-25 CA CA2654981A patent/CA2654981C/en active Active
- 2007-07-25 AU AU2007277201A patent/AU2007277201B2/en active Active
- 2007-07-25 JP JP2009521827A patent/JP2009544315A/ja not_active Withdrawn
- 2007-07-25 EP EP07810786A patent/EP2044444B1/en active Active
-
2010
- 2010-11-11 US US12/944,586 patent/US8318501B2/en not_active Expired - Fee Related
-
2012
- 2012-08-27 JP JP2012186627A patent/JP5878096B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-02 JP JP2013207006A patent/JP2013255519A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20110189712A1 (en) | 2011-08-04 |
| AU2007277201B2 (en) | 2014-01-09 |
| WO2008013874A1 (en) | 2008-01-31 |
| EP2044444A1 (en) | 2009-04-08 |
| ES2404059T3 (es) | 2013-05-23 |
| US8318501B2 (en) | 2012-11-27 |
| JP2013255519A (ja) | 2013-12-26 |
| CA2654981A1 (en) | 2008-01-31 |
| US20080096230A1 (en) | 2008-04-24 |
| JP2009544315A (ja) | 2009-12-17 |
| US7855079B2 (en) | 2010-12-21 |
| JP5878096B2 (ja) | 2016-03-08 |
| EP2044444B1 (en) | 2013-03-20 |
| JP2012233922A (ja) | 2012-11-29 |
| CN101484809B (zh) | 2013-12-04 |
| AU2007277201A1 (en) | 2008-01-31 |
| CN101484809A (zh) | 2009-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2654981C (en) | Methods for assaying percentage of glycated hemoglobin | |
| US8557591B2 (en) | Methods for assaying percentage of glycated hemoglobin | |
| USRE46130E1 (en) | Method of selectively determining glycated hemoglobin | |
| EP1693461B1 (en) | Method of assaying glycated protein | |
| JP5870919B2 (ja) | 糖化ヘモグロビンの測定方法 | |
| CN1625601B (zh) | 利用氧化还原反应的糖化蛋白质的测定方法及测定试剂盒 | |
| EP2210113B1 (en) | Methods for the detection of glycated hemoglobin | |
| Hirokawa et al. | An enzymatic method for the determination of hemoglobinA1C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |